“Every Rose has a Fiber” The extracellular matrix in a mouse model of triple negative breast cancer. (Tenascin-C = red, Fibronectin = green, DAPI = blue)
Month: March 2022
Congratulations to Shelby Fertal on the publication of her review article on the stromal impacts on new therapies for TNBC patients!
In this collaborative review with Drs. Kari Wisinski and Johanna Poterala, we summarize the recent outcomes from clinical trials with new agents for metastatic triple-negative breast cancer, specifically focusing on immunotherapies targeting the PD-1/PD-L1 pathway …